Bellerophon Therapeutics, Inc.
BLPHDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001600132
Bellerophon Therapeutics, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Oct 16, 2023; 22 institutions reported holding it in 13F filings for Q3 2023, worth $506.6K in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Bellerophon Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −1 vs. Q2 2023
- Shares held
- 1.27M
- +75.4K (+6.3%) vs. Q2 2023
- Total value
- $506.6K
- −$318.4K (−38.6%) vs. Q2 2023
- New holders
- 4
- 3 more added
- Sold out
- 5
- 8 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BLPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 2 | $6.37K |
| Q3 2023 | 22 | $506.6K |
| Q2 2023 | 23 | $824.9K |
| Q1 2023 | 19 | $27.9M |
| Q4 2022 | 25 | $832.7K |
| Q3 2022 | 19 | $1.18M |
| Q2 2022 | 19 | $1.40M |
| Q1 2022 | 22 | $2.68M |
| Q4 2021 | 22 | $3.82M |
| Q3 2021 | 22 | $4.81M |
| Q2 2021 | 27 | $6.34M |
| Q1 2021 | 39 | $10.9M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Bellerophon Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Acadian Asset Management LLC | 383,178 | $152.0K | 0.00% | +117,925+44.5% | Added |
| Wells Fargo & Company | 180,066 | $71.6K | 0.00% | −20,009−10.0% | Reduced |
| Vanguard Group Inc | 145,810 | $58.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 127,723 | $50.8K | 0.00% | −2,153−1.7% | Reduced |
| Two Sigma Investments, LP | 113,911 | $45.3K | 0.00% | +10,124+9.8% | Added |
| Geode Capital Management, LLC | 95,656 | $38.3K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 59,499 | $24.0K | 0.00% | −17,800−23.0% | Reduced |
| Citadel Advisors LLC | 42,717 | $17.1K | 0.00% | +42,717 | New |
| State Street Corp | 30,127 | $12.1K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 30,251 | $12.0K | 0.00% | −7,970−20.9% | Reduced |
| Two Sigma Advisers, LP | 21,500 | $8.55K | 0.00% | +6,600+44.3% | Added |
| Susquehanna International Group, LLP | 15,313 | $6.13K | 0.00% | +15,313 | New |
| Raymond James & Associates | 10,000 | $3.98K | 0.00% | −1,097−9.9% | Reduced |
| Tower Research Capital LLC (TRC) | 7,135 | $2.84K | 0.00% | −15−0.2% | Reduced |
| PFS Partners, LLC | 6,000 | $2.39K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 2,100 | $840 | 0.00% | −1,800−46.2% | Reduced |
| US Bancorp | 1,221 | $485 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 557 | $221 | 0.00% | −30,057−98.2% | Reduced |
| Qube Research & Technologies Ltd | 52 | $21 | 0.00% | +52 | New |
| Global Wealth Strategies & Associates | 50 | $20 | 0.00% | +50 | New |
| GPS Wealth Strategies Group, LLC | 38 | $15 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 33 | $13 | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −25,870−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −10,355−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −192−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −95−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |